✦ LIBER ✦

Comparison of Inflammatory Markers and Lipid Profile Between High-dose Rosuvastatin Monotherapy and Ezetimibe / Rosuvastatin Combination Therapy

✍ Scribed by Daisuke Yamazaki; Masaru Ishida; Kiyoshi Nobori; Yasunori Oguma; Yutaka Terata; Takashi Koyama; Kenji Iino; Toshimitsu Kosaka; Hiroyuki Watanabe; Hiroshi Ito

Book ID: 119214815
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 64 KB
Volume: 18
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2012.08.202

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of anti-inflammatory effects

Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe

✍ Daisuke Yamazaki, Masaru Ishida, Hiroyuki Watanabe… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 367 KB

Comparison of the effects of maximal dos

Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers

✍ van Himbergen, T. M.; Matthan, N. R.; Resteghini, N. A.; Otokozawa, S.; Ai, M.; 📂 Article 📅 2008 🏛 Lipid Research, Inc. 🌐 English ⚖ 677 KB

PCV5 A REALWORLD COMPARISON OF COMBINED

PCV5 A REALWORLD COMPARISON OF COMBINED LIPID TARGET ATTAINMENT BETWEEN COMBINATION NIACIN EXTENDED-RELEASE+ANY STATIN THERAPY AND FIXED DOSE SIMVASTATIN+EZETIMIBE

✍ RJ Simko; RA Quimbo; MJ Cziraky; S Balu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Effects of Pioglitazone and Metformin Fi

Effects of Pioglitazone and Metformin Fixed-Dose Combination Therapy on Cardiovascular Risk Markers of Inflammation and Lipid Profile Compared With Pioglitazone and Metformin Monotherapy in Patients With Type 2 Diabetes

✍ Alfonso Perez; Randal Jacks; Vipin Arora; Robert Spanheimer 📂 Article 📅 2010 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 449 KB